[
  {
    "ts": "2025-07-22T16:55:00+00:00",
    "headline": "Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis",
    "summary": "Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.",
    "url": "https://finance.yahoo.com/news/vertex-announces-marketing-authorization-canada-165500211.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "84b49746-3fa2-3af0-88e4-d5be0912d57d",
      "content": {
        "id": "84b49746-3fa2-3af0-88e4-d5be0912d57d",
        "contentType": "STORY",
        "title": "Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis",
        "description": "",
        "summary": "Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.",
        "pubDate": "2025-07-22T16:55:00Z",
        "displayTime": "2025-07-22T16:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/12078a882871e2b1185224321b16668a",
          "originalWidth": 400,
          "originalHeight": 210,
          "caption": "Logo du Vertex Pharmaceuticals (CNW Group/Vertex Pharmaceuticals (Canada) Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n3o037dF21DTeTnxrPlHqg--~B/aD0yMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/12078a882871e2b1185224321b16668a.cf.webp",
              "width": 400,
              "height": 210,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tyM18lHIeZLPPWShsiSOLA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/12078a882871e2b1185224321b16668a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-announces-marketing-authorization-canada-165500211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-announces-marketing-authorization-canada-165500211.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-22T11:38:20+00:00",
    "headline": "Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to Know",
    "summary": "Vertex Pharmaceuticals is all set to release its fiscal second-quarter earnings next month, and analysts project a robust triple-digit earnings growth.",
    "url": "https://www.barchart.com/story/news/33551052/vertex-pharmaceuticals-quarterly-earnings-preview-what-you-need-to-know",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "b5bc3499-8632-30c4-a176-1b47be5e168f",
      "content": {
        "id": "b5bc3499-8632-30c4-a176-1b47be5e168f",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to Know",
        "description": "",
        "summary": "Vertex Pharmaceuticals is all set to release its fiscal second-quarter earnings next month, and analysts project a robust triple-digit earnings growth.",
        "pubDate": "2025-07-22T11:38:20Z",
        "displayTime": "2025-07-22T11:38:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "Vertex Pharmaceuticals, Inc_ HQ in Boston-by Tada Images via Shuttershock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Shb7JdZjS3KjsEy4OVFfew--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EMGmPiWDsIHqjC0QyY.H8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/33551052/vertex-pharmaceuticals-quarterly-earnings-preview-what-you-need-to-know",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-quarterly-earnings-preview-113820558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-22T08:14:00+00:00",
    "headline": "3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results",
    "summary": "Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials.  Shares of these drugmakers could jump if the data from the studies is positive.  Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials.",
    "url": "https://www.fool.com/investing/2025/07/22/3-healthcare-stocks-to-buy-before-they-announce-ga/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d628c413-0939-33e9-864e-75a08de66f40",
      "content": {
        "id": "d628c413-0939-33e9-864e-75a08de66f40",
        "contentType": "STORY",
        "title": "3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results",
        "description": "",
        "summary": "Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials.  Shares of these drugmakers could jump if the data from the studies is positive.  Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials.",
        "pubDate": "2025-07-22T08:14:00Z",
        "displayTime": "2025-07-22T08:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/ea9cb0fe832a9b981cb6643c763f1474",
          "originalWidth": 1400,
          "originalHeight": 828,
          "caption": "Pharmacist talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXHs3GKUfe15F4trLbQ5DQ--~B/aD04Mjg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/ea9cb0fe832a9b981cb6643c763f1474.cf.webp",
              "width": 1400,
              "height": 828,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4zxUbnK4FiZAvr4KMrgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/ea9cb0fe832a9b981cb6643c763f1474.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/07/22/3-healthcare-stocks-to-buy-before-they-announce-ga/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-healthcare-stocks-buy-announce-081400571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "SMMT"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]